Capital International Investors
AGIO icon

Capital International Investors’s Agios Pharmaceuticals AGIO Stock Holding History

Capital International Investors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-48,616
Closed -$1.64M – 448
2026
Q1 		$1.64M Sell
48,616
-655,249
-93% -$18.6M ﹤0.01% 423
2025
Q4 		$19.2M Buy
+703,865
New +$24.7M ﹤0.01% 401
2021
Q3 		– Sell
-95,882
Closed -$5.28M – 460
2021
Q2 		$5.28M Hold
95,882
– – ﹤0.01% 436
2021
Q1 		$4.95M Sell
95,882
-122,168
-56% -$6.05M ﹤0.01% 427
2020
Q4 		$9.45M Sell
218,050
-3,217,303
-94% -$127M ﹤0.01% 411
2020
Q3 		$120M Sell
3,435,353
-419,479
-11% -$18.4M 0.04% 254
2020
Q2 		$206M Sell
3,854,832
-133,688
-3% -$6.19M 0.07% 208
2020
Q1 		$142M Sell
3,988,520
-544,294
-12% -$25.2M 0.06% 196
2019
Q4 		$216M Sell
4,532,814
-97,234
-2% -$3.67M 0.07% 186
2019
Q3 		$150M Buy
4,630,048
+1,371,522
+42% +$56.8M 0.06% 203
2019
Q2 		$163M Buy
3,258,526
+10,613
+0.3% +$567K 0.06% 201
2019
Q1 		$219M Buy
3,247,913
+14,744
+0.5% +$859K 0.09% 175
2018
Q4 		$149M Buy
3,233,169
+136,747
+4% +$8.44M 0.07% 183
2018
Q3 		$239M Buy
3,096,422
+291,393
+10% +$23.4M 0.11% 169
2018
Q2 		$236M Sell
2,805,029
-17,255
-0.6% -$1.5M 0.27% 112
2018
Q1 		$231M Buy
2,822,284
+9,182
+0.3% +$710K 0.27% 112
2017
Q4 		$161M Sell
2,813,102
-325,029
-10% -$20.5M 0.18% 130
2017
Q3 		$209M Buy
3,138,131
+8,294
+0.3% +$498K 0.25% 118
2017
Q2 		$161M Buy
3,129,837
+325,310
+12% +$16.6M 0.22% 125
2017
Q1 		$164M Buy
2,804,527
+8,241
+0.3% +$395K 0.22% 122
2016
Q4 		$117M Buy
2,796,286
+1,291,390
+86% +$67.8M 0.17% 141
2016
Q3 		$79.5M Buy
1,504,896
+3,859
+0.3% +$168K 0.12% 170
2016
Q2 		$62.9M Buy
1,501,037
+153,464
+11% +$7.58M 0.09% 182
2016
Q1 		$54.7M Buy
1,347,573
+568
+0% +$24.3K 0.08% 191
2015
Q4 		$87.4M Buy
1,347,005
+1,833
+0.1% +$120K 0.14% 159
2015
Q3 		$95M Buy
1,345,172
+224,661
+20% +$22M 0.17% 141
2015
Q2 		$125M Buy
1,120,511
+56,111
+5% +$6.04M 0.21% 135
2015
Q1 		$100M Buy
1,064,400
+208,000
+24% +$23.3M 0.18% 141
2014
Q4 		$96M Buy
+856,400
New +$76.5M 0.2% 135

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Capital International Investors's AGIO Position: Q2 2026 in Review

Capital International Investors sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 48,616 shares — an estimated $1.64M sold.

Capital International Investors first reported a position in AGIO in Q4 2014 and held it in 29 quarters. The position peaked at $239M in Q3 2018. 157 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Capital International Investors reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Capital International Investors sold 48,616 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.64M.
  • Capital International Investors first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 29 quarters.
  • Capital International Investors's Agios Pharmaceuticals position peaked at $239M in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.